(Q54399364)

English

Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

Radical cystectomy

0 references

author name string

Steven A Schneider

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

William R Sukov

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Igor Frank

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Stephen A Boorjian

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Brian A Costello

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Robert F Tarrell

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Prabin Thapa

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

R Houston Thompson

8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Matthew K Tollefson

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

R Jeffrey Karnes

10

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

John C Cheville

11

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

publication date

1 November 2013

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

Modern Pathology

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

27

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

758-764

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.201

0 references

Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Invasive micropapillary urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Imaging of HER-2 overexpression in tumors for guiding therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Dynamic and modern: bringing the ethics of phase I trials up to date.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

21 January 2018

Micropapillary carcinoma of the urothelial tract. A clinicopathologic study of 38 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

7 January 2021

based on heuristic

inferred from DOI database lookup

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2013.201

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/24186136

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54399364&oldid=1603747306"